Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
McKesson
Cantor Fitzgerald
Chinese Patent Office
Deloitte
Boehringer Ingelheim
Cipla
Dow

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060456

« Back to Dashboard

NDA 060456 describes PENICILLIN-VK, which is a drug marketed by Teva and is included in two NDAs. It is available from eight suppliers. Additional details are available on the PENICILLIN-VK profile page.

The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are ninety drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for 060456
Tradename:PENICILLIN-VK
Applicant:Teva
Ingredient:penicillin v potassium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 060456
Ingredient-typePenicillins
Suppliers and Packaging for NDA: 060456
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA Inc 0093-4125 N 0093-4125-73
PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA Inc 0093-4125 N 0093-4125-74

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 125MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 250MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Dow
UBS
QuintilesIMS
US Department of Justice
Cantor Fitzgerald
Queensland Health
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.